AJINOMOTO CO INC

Overview

AJINOMOTO CO INC is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering AMINO ACID PRODUCTS; L-ARGININE; L-ARGININE MONOHYDROCHLORIDE; L-ASPARTIC ACID; L-GLUTAMIC ACID; L-LYSINE MONOHYDROCHLORIDE.

API / Drug Master Files

AJINOMOTO CO INC holds 10 active (25 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LEVODOPAActive2017-04-20
• L-PHENYLALANINEActive2017-04-20
• L-GLUTAMIC ACIDActive2017-04-20
• L-LYSINE MONOHYDROCHLORIDEActive2017-04-20
• L-ASPARTIC ACIDActive2017-04-20
• L-TYROSINEActive2017-04-20
• L-ARGININE MONOHYDROCHLORIDEActive2017-04-20
• L-ARGININEActive2017-04-20
• LEVODOPAActive1997-02-19
• AMINO ACID PRODUCTSActive1967-08-15
• L-LYSINE ACETATEInactive2017-04-20
• ADENOSINEInactive2004-08-16
• AT-1015 A 5-HT2A ANTAGONISTInactive1999-05-03
• MANUFACTURING SITE, FACILITIES, PERSONNEL AND OPERATING PROCEDURES IN YOKKAICHI, MIE PREFECTURE, JAPANInactive1998-06-23
• A-84538.0 (RITONAVIR)Inactive1995-09-25

Showing 15 of 25 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to AJINOMOTO CO INC in our records. PharmaTek screens the full directory against live FDA enforcement data.